Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miso Kim

Showing results (151-160 of 184) with videos related to

Pageof 19
Sort By:
Lung Cancer (Amsterdam, Netherlands)|November 7, 2025
Phase II study of lazertinib and pemetrexed in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer with leptomeningeal metastases: the KCSG LU 21-01, LAZARUS studyHyun Ae Jung, Tae Min Kim, Hye Ryun Kim, et al.
Journal of the American Academy of Dermatology|September 6, 2022
First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600-mutant advanced melanomaChang Gon Kim, Miso Kim, Jieon Hwang, et al.
Cancer Research and Treatment|August 20, 2021
A Real-world Efficacy of Nab-paclitaxel Monotherapy in Metastatic Breast CancerJung Sun Kim, Koung Jin Suh, Dae-Won Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2022
A Phase 2 Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors (KCSG LU17-21)Hyun Ae Jung, Miso Kim, Hae Su Kim, et al.
Investigative and Clinical Urology|July 12, 2019
Establishment of the Seoul National University Prospectively Enrolled Registry for Genitourinary Cancer (SUPER-GUC): A prospective, multidisciplinary, bio-bank linked cohort and research platformChang Wook Jeong, Jungyo Suh, Hyeong Dong Yuk, et al.
Oncotarget|February 20, 2016
PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinomaChan-Young Ock, Sehui Kim, Bhumsuk Keam, et al.
Experimental & Molecular Medicine|August 23, 2022
DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapyHaejeong Heo, Jong-Hwan Kim, Hyun Jung Lim, et al.
NPJ Breast Cancer|July 17, 2024
Differential effects of desvenlafaxine on hot flashes in women with breast cancer taking tamoxifen: a randomized controlled trialYongjoo Kim, Chan-Woo Yeom, Hyun Jeong Lee, et al.
Cancer Immunology, Immunotherapy : CII|November 24, 2020
Pan-cancer methylation analysis reveals an inverse correlation of tumor immunogenicity with methylation aberrancyChanghee Park, Kyeonghun Jeong, Joon-Hyeong Park, et al.
Theranostics|September 15, 2020
Tumor immune profiles noninvasively estimated by FDG PET with deep learning correlate with immunotherapy response in lung adenocarcinomaChanghee Park, Kwon Joong Na, Hongyoon Choi, et al.
Pageof 19

Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
Lung Cancer (Amsterdam, Netherlands)|November 7, 2025
Phase II study of lazertinib and pemetrexed in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer with leptomeningeal metastases: the KCSG LU 21-01, LAZARUS studyHyun Ae Jung, Tae Min Kim, Hye Ryun Kim, et al.
Journal of the American Academy of Dermatology|September 6, 2022
First-line pembrolizumab versus dabrafenib/trametinib treatment for BRAF V600-mutant advanced melanomaChang Gon Kim, Miso Kim, Jieon Hwang, et al.
Cancer Research and Treatment|August 20, 2021
A Real-world Efficacy of Nab-paclitaxel Monotherapy in Metastatic Breast CancerJung Sun Kim, Koung Jin Suh, Dae-Won Lee, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 28, 2022
A Phase 2 Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumors (KCSG LU17-21)Hyun Ae Jung, Miso Kim, Hae Su Kim, et al.
Investigative and Clinical Urology|July 12, 2019
Establishment of the Seoul National University Prospectively Enrolled Registry for Genitourinary Cancer (SUPER-GUC): A prospective, multidisciplinary, bio-bank linked cohort and research platformChang Wook Jeong, Jungyo Suh, Hyeong Dong Yuk, et al.
Oncotarget|February 20, 2016
PD-L1 expression is associated with epithelial-mesenchymal transition in head and neck squamous cell carcinomaChan-Young Ock, Sehui Kim, Bhumsuk Keam, et al.
Experimental & Molecular Medicine|August 23, 2022
DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapyHaejeong Heo, Jong-Hwan Kim, Hyun Jung Lim, et al.
NPJ Breast Cancer|July 17, 2024
Differential effects of desvenlafaxine on hot flashes in women with breast cancer taking tamoxifen: a randomized controlled trialYongjoo Kim, Chan-Woo Yeom, Hyun Jeong Lee, et al.
Cancer Immunology, Immunotherapy : CII|November 24, 2020
Pan-cancer methylation analysis reveals an inverse correlation of tumor immunogenicity with methylation aberrancyChanghee Park, Kyeonghun Jeong, Joon-Hyeong Park, et al.
Theranostics|September 15, 2020
Tumor immune profiles noninvasively estimated by FDG PET with deep learning correlate with immunotherapy response in lung adenocarcinomaChanghee Park, Kwon Joong Na, Hongyoon Choi, et al.
Pageof 19